For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
X4 Pharmaceuticals Inc (NASDAQ: XFOR) closed the day trading at $0.75 down -1.34% from the previous closing price of $0.76. In other words, the price has decreased by -$1.34 from its previous closing price. On the day, 1.38 million shares were traded. XFOR stock price reached its highest trading level at $0.785 during the session, while it also had its lowest trading level at $0.7492.
Ratios:
For a better understanding of XFOR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.04 and its Current Ratio is at 6.07. In the meantime, Its Debt-to-Equity ratio is 0.83 whereas as Long-Term Debt/Eq ratio is at 0.82.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on December 12, 2023, Downgraded its rating to Neutral and sets its target price to $1 from $3 previously.
On December 22, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $3.Cantor Fitzgerald initiated its Overweight rating on December 22, 2022, with a $3 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 11 ’24 when Taveras Arthur sold 14,235 shares for $0.88 per share. The transaction valued at 12,552 led to the insider holds 234,301 shares of the business.
Ragan Paula sold 49,678 shares of XFOR for $43,856 on Mar 11 ’24. The President and CEO now owns 765,068 shares after completing the transaction at $0.88 per share. On Mar 11 ’24, another insider, Mostafa Adam S., who serves as the Chief Financial Officer of the company, sold 52,500 shares for $0.88 each. As a result, the insider received 46,347 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XFOR now has a Market Capitalization of 126375000 and an Enterprise Value of 35848636. As of this moment, X4’s Price-to-Earnings (P/E) ratio for their current fiscal year is 8.76. For the stock, the TTM Price-to-Sale (P/S) ratio is 225.67 while its Price-to-Book (P/B) ratio in mrq is 1.34. Its current Enterprise Value per Revenue stands at 63.674 whereas that against EBITDA is -0.291.
Stock Price History:
Over the past 52 weeks, XFOR has reached a high of $1.60, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is -1.21%, while the 200-Day Moving Average is calculated to be -17.27%.
Shares Statistics:
Over the past 3-months, XFOR traded about 2.03M shares per day on average, while over the past 10 days, XFOR traded about 1095480 shares per day. A total of 167.43M shares are outstanding, with a floating share count of 117.62M. Insiders hold about 30.19% of the company’s shares, while institutions hold 38.56% stake in the company. Shares short for XFOR as of 1722384000 were 14715092 with a Short Ratio of 7.24, compared to 1719532800 on 13882654. Therefore, it implies a Short% of Shares Outstanding of 14715092 and a Short% of Float of 8.83.